BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4817255)

  • 1. Proceedings: Biochemical studies on a patient with features suggestive of hereditary tyrosinaemia.
    Chalmers RA; Liberman M; Watts RW
    Clin Sci Mol Med; 1974 Feb; 46(2):14P. PubMed ID: 4817255
    [No Abstract]   [Full Text] [Related]  

  • 2. The enzyme defects in hereditary tyrosinaemia type I.
    Furukawa N; Hayano T; Sato N; Inoue F; Machida Y; Kinugasa A; Imashuku S; Kusunoki T; Takamatisu T
    J Inherit Metab Dis; 1984; 7 Suppl 2():137-8. PubMed ID: 6434869
    [No Abstract]   [Full Text] [Related]  

  • 3. The source of aromatic ketoacids in tyrosinaemia and phenylketonuria.
    Fellman JH; Buist NR; Kennaway NG; Swanson RE
    Clin Chim Acta; 1972 Jun; 39(1):243-6. PubMed ID: 4402641
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary tyrosinemia: metabolic studies in a patient with partial p-hydroxyphenylpyruvate hydroxylase activity.
    Jagenburg R; Landblad B; De Maré JM; Rödjer S
    J Pediatr; 1972 Jun; 80(6):994-1004. PubMed ID: 5026040
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical observations on so-called hereditary tyrosinemia.
    Gaull GE; Rassin DK; Solomon GE; Harris RC; Sturman JA
    Pediatr Res; 1970 Jul; 4(4):337-44. PubMed ID: 4393588
    [No Abstract]   [Full Text] [Related]  

  • 6. An exceptional case of tyrosinosis.
    Wadman SK; van Sprang FJ; Maas JW; Ketting D
    J Ment Defic Res; 1968 Dec; 12(4):269-81. PubMed ID: 5729527
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.
    Gentz J; Lindblad B; Lindstedt S; Zetterström R
    J Lab Clin Med; 1969 Aug; 74(2):185-202. PubMed ID: 5799507
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal hyperphenylalaninemia: a differential diagnosis.
    Menkes JH; Holtzman NA
    Neuropadiatrie; 1970 Apr; 1(4):434-46. PubMed ID: 5538081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental hyperphenylalanaemic animals and cystathionine contents in brain tissues].
    Shoma N
    Nihon Seirigaku Zasshi; 1970; 32(4):219-28. PubMed ID: 4987953
    [No Abstract]   [Full Text] [Related]  

  • 10. Tyrosinosis: a patient without liver or renal disease.
    Holston JL; Levy HL; Tomlin GA; Atkins RJ; Patton TH; Hosty TS
    Pediatrics; 1971 Sep; 48(3):393-400. PubMed ID: 5094340
    [No Abstract]   [Full Text] [Related]  

  • 11. Tyrosinaemia type I with normal levels of plasma tyrosine.
    de Almeida IT; Leandro PP; Silva MF; Silveira C; da Silva A; de Sousa JS; Duran M
    J Inherit Metab Dis; 1990; 13(3):305-7. PubMed ID: 2122090
    [No Abstract]   [Full Text] [Related]  

  • 12. Gas-liquid chromatography of phenylalanine metabolites in urine and sera of hyperphenylalaninemic and phenylketonuric patients.
    Kitagawa T
    Clin Chem; 1974 Dec; 20(12):1543-7. PubMed ID: 4430132
    [No Abstract]   [Full Text] [Related]  

  • 13. Type I hereditary tyrosinaemia: presentation of 11 cases.
    Coşkun T; Ozalp I; Koçak N; Yüce A; Caglar M; Berger R
    J Inherit Metab Dis; 1991; 14(5):765-70. PubMed ID: 1664010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary phenolic acids in tyrosinemia. Identification and quantitation by gas chromatography-mass spectrometry.
    Crawhall JC; Mamer O; Tjoa S; Claveau JC
    Clin Chim Acta; 1971 Aug; 34(1):47-54. PubMed ID: 5118727
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.
    Curtius HC; Völlmin JA; Baerlocher K
    Clin Chim Acta; 1972 Mar; 37():277-85. PubMed ID: 5022091
    [No Abstract]   [Full Text] [Related]  

  • 16. The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC-MS assay for succinylacetone.
    Pettit BR; MacKenzie F; King GS; Leonard JV
    J Inherit Metab Dis; 1984; 7 Suppl 2():135-6. PubMed ID: 6434868
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical studies in a patient with "tyrosinosis".
    Louis WJ; Pitt DD; Davies H
    Aust N Z J Med; 1974 Jun; 4(3):281-6. PubMed ID: 4531904
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased excretion of coproporphyrin I in a patient with hereditary tyrosinaemia type I: relevant changes with NTBC treatment.
    Depetris-Boldini C; Galetto R; Videla MP; de Kremer Dodelson R
    J Inherit Metab Dis; 1999 May; 22(3):227-30. PubMed ID: 10384374
    [No Abstract]   [Full Text] [Related]  

  • 19. Microassay of tyrosine-amino transferase and p-hydroxyphenylpyruvic acid oxidase in mammalian liver and patients with hereditary tyrosinemia.
    Whelan DT; Zannoni VG
    Biochem Med; 1974 Jan; 9(1):19-31. PubMed ID: 4150247
    [No Abstract]   [Full Text] [Related]  

  • 20. The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency.
    Kennaway NG; Buist NR; Fellman JH
    Clin Chim Acta; 1972 Oct; 41():157-61. PubMed ID: 4405100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.